| EC | Half-maximal effective concentration |
| EMA | European Medecines Agency |
| FDA | US Food and Drug Administration |
| IC | Half-maximal inhibitory concentration |
| LRT | Lower respiratory tract |
| MERS-CoV | Middle East respiratory syndrome coronavirus |
| PBMCs | Peripheral blood mononuclear cells |
| PK | Pharmacokinetic |
| PD | Pharmacodynamic |
| TE | Target engagement |
| RdRp | RNA-dependent RNA polymerase |
| RDV | Remdesivir |
| RDV-TP | Remdesivir’s active triphosphate metabolite, GS-443902 |
| URT | Upper respiratory tract |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.